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The M protein of Streptococcus canis (SCM) is a virulence factor and serves as a
surface-associated receptor with a particular affinity for mini-plasminogen, a cleavage
product of the broad-spectrum serine protease plasmin. Here, we report that SCM has an
additional high-affinity immunoglobulin G (IgG) binding activity. The ability of a particular
S. canis isolate to bind to IgG significantly correlates with a scm-positive phenotype,
suggesting a dominant role of SCM as an IgG receptor. Subsequent heterologous
expression of SCM in non-IgG binding S. gordonii and Western Blot analysis with
purified recombinant SCM proteins confirmed its IgG receptor function. As expected
for a zoonotic agent, the SCM-IgG interaction is species-unspecific, with a particular
affinity of SCM for IgGs derived from human, cats, dogs, horses, mice, and rabbits,
but not from cows and goats. Similar to other streptococcal IgG-binding proteins,
the interaction between SCM and IgG occurs via the conserved Fc domain and is,
therefore, non-opsonic. Interestingly, the interaction between SCM and IgG-Fc on the
bacterial surface specifically prevents opsonization by C1q, which might constitute
another anti-phagocytic mechanism of SCM. Extensive binding analyses with a variety
of different truncated SCM fragments defined a region of 52 amino acids located in
the central part of the mature SCM protein which is important for IgG binding. This
binding region is highly conserved among SCM proteins derived from different S. canis
isolates but differs significantly from IgG-Fc receptors of S. pyogenes and S. dysgalactiae
sub. equisimilis, respectively. In summary, we present an additional role of SCM in the
pathogen-host interaction of S. canis. The detailed analysis of the SCM-IgG interaction
should contribute to a better understanding of the complex roles of M proteins in
streptococcal pathogenesis.
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INTRODUCTION
Streptococcus (S.) canis is an opportunistic pathogen which colonizes the mucosal surfaces and skin
of a variety of different animal species. Domestic carnivores, such as dogs and cats, constitute the
main hosts, but S. canis has also been found in other mammalian species such as rats, minks,
mice, rabbits, and foxes (Corning et al., 1991; Iglauer et al., 1991). Predisposing conditions, such
Bergmann et al. Interaction of S. canis SCM with Immunoglobulin G
as age, underlying diseases, or immunodeficiencies, can lead
to infection caused by S. canis. Clinical manifestations range
from localized infections of skin and mucosa to severe and life-
threatening diseases, such as streptococcal toxic shock syndrome,
necrotizing fasciitis, septicemia, and meningitis (DeWinter and
Prescott, 1999; Kruger et al., 2010; Lamm et al., 2010). Very
recently, S. canis has also been characterized as a zoonotic
pathogen, based on reports of transmission resulting from close
contact between humans and dogs and from bite injuries (Bert
and Lambert-Zechovsky, 1997; Galperine et al., 2007; Lam et al.,
2007; Takamura et al., 2009; Lacave et al., 2016; Tan et al., 2016).
However, human infections with S. canis do not necessarily
require contact with dogs or cats (Amsallem et al., 2014).
The emerging resistances of bacteria against one or multiple
antibiotics demands scientific efforts to develop alternative
therapeutic approaches against infectious agents. A specific
intervention in bacterial-host interactions is a promising
approach, but requires profound knowledge of the molecular
bases of bacterial virulence traits. However, with only very
few exceptions, there is scant knowledge about the virulence
mechanisms of S. canis. Yang et al. (2010) identified a protein
with homologies to the Streptococcal Protective Antigen (SPA) of
S. pyogenes and S. equi, which facilitates protection in a murine
infection model after passive immunization (Yang et al., 2010).
Hitzmann and co-workers described the Arginine Deiminase
System in S. canis, which confers resistance against acidic
conditions, as found in the host cell phagolysosome (Hitzmann
et al., 2013). Finally, we previously identified a surface-associated
protein with structural and functional, but not genetic similarities
to the M protein family of streptococci, which we therefore
designated SCM for S. canisM protein (Fulde et al., 2011).
SCM is a fibrillar protein which is found in the majority of
S. canis isolates (Verkuehlen et al., 2016). The protein exhibits a
molecular weight of∼45 kDa and contains heptameric sequence
repeats with hydrophobic amino acids at position 1 and 4
leading to an almost alpha helical protein structure with a
high tendency for dimerization. Functionally, SCM constitutes a
bacterial receptor for host plasminogen (Plg) with a particular
affinity for the cleavage product mini-Plg. Plg is a zymogen
for the broad-spectrum serine protease plasmin. Although S.
canis is not able to intrinsically activate Plg, plasmin can be
immobilized onto the bacterial surface via SCM, where its
enzymatic activity can degrade fibrinogen and aggregate fibrin
thrombi (Fulde et al., 2011, 2013a,b). Plasmin mediated tissue
degradation is an important virulence trait of disseminative
streptococcal infections (Sun et al., 2004).
A major characteristic of streptococcal M proteins is their
anti-phagocytic potential. The underlying mechanisms are
versatile and include the demasking of bacterial antigens by host-
derived extracellularmatrix or serum proteins, circumventing the
host’s complement attack by binding to complement inhibitors
or enlarging the bacterial surface by M protein mediated
self-aggregation (Whitnack and Beachey, 1982; Horstmann
et al., 1988; Kotarsky et al., 1998; Frick et al., 2000;
Berggard et al., 2001; Morfeldt et al., 2001; Fulde et al.,
2013a). A well-characterized anti-phagocytic immune evasion
mechanism of streptococcal M and M-like proteins is their
interaction with immunoglobulins. Immunoglobulins (Igs)
constitute the main arm of the adaptive humoral immune
response. Certain Ig- subtypes, such as immunoglobulin G
(IgG), mediate an anti-bacterial immune mechanism referred
to as opsono-phagocytosis. Opsono-phagocytosis is a bipartite
process, consisting of an antigen-specific interaction between
the F(ab) part of IgG and the bacterium, and an interaction
between the constant fragment crystallizable (Fc) part of IgGwith
a specific Fc-receptor, which is usually localized on professional
phagocytic immune cells, such as macrophages and granulocytes.
IgG-Fc receptors per se are versatile and widespread among
bacterial species, irrespective of their pathogenicity, metabolism,
or their cell wall composition (Forsgren and Sjöquist, 1969;
Bjorck and Kronvall, 1984; Zav’yalov et al., 1996; Meehan et al.,
2001, 2009; Lewis et al., 2008; Leo and Goldman, 2009). In
streptococci, however, non-immune binding to the IgG-Fc region
is mediated exclusively by members of the M and M-like protein
families, such as protein G and FOG (the fibrinogen binding
protein of group G streptococci) of S. dysgalactiaesub. equisimilis
(SDSE), protein H and differentM proteins of S. pyogenes (Group
A streptococci, GAS), SzM of S. equi subsp. zooepidemicus, and
the fibrinogen binding protein (FgBP) of S. equi subsp. equi
(reviewed in Nobbs et al., 2009).
In this study, we describe SCM, the M protein of S. canis,
as a novel IgG-binding protein, which specifically interacts
with the constant Fc part in a non-opsonic manner. This
work represents a comprehensive study on molecular and
biochemical mechanisms, which characterizes the IgG-SCM
interaction in detail and finally helps to expand our knowledge
about streptococcal IgG-Fc receptors.
METHODS
Bacterial Strains and Growth Conditions
Streptococcus canis strains used in this study have previously been
described (Fulde et al., 2011, 2013a; Verkuehlen et al., 2016).
Additional isolates (5539-1-10, 5480-2-10, 5468-1-10, and 5520-
2-10) were kindly provided by Dr. Jutta Verspohl (University
of Veterinary Medicine Hannover). Where indicated, the scm-
genotype was evaluated by PCR essentially as described earlier
(Verkuehlen et al., 2016). Generation of a S. gordonii strain
heterologously expressing SCM and its SCM-negative parental
strain were described in a prior study (Fulde et al., 2011). SDSE
strain G45 and its FOG-negative deletion mutant G89 were
described earlier (Nitsche-Schmitz et al., 2007). Bacteria were
routinely grown in tryptic soy broth (TSB) at 37◦C without
shaking. Escherichia coli strains were cultivated in Luria-Bertani-
Medium. Where indicated, antibiotics were supplemented in
the following concentrations. E. coli: Ampicillin (100 µg/ml),
kanamycin (25 µg/ml); S. gordonii: Erythromycin (1 µg/ml).
Proteins and Sera
Human IgG, different subclasses of human IgG, and papain-
treated fragments of human IgG as well as human plasminogen
were purchased from Sigma. C1q was purchased from
Calbiochem. Polyclonal antibodies against human plasminogen
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and secondary, HRP-conjugated anti-rabbit, anti-mouse, and
anti-human antibodies were purchased from Dako.
Radioactive Labeling, Binding, and
Inhibition Studies
Iodination of IgG, Plg, and SCM was performed according to the
chloramine T method essentially as described earlier (Chhatwal
et al., 1987). Binding and competition studies were carried out as
described in Fulde et al. (2011, 2013a).
Flow Cytometry Analyses
Bacteria were grown to mid-exponential phase in TSB medium,
sedimented by centrifugation at 1,400× g for 10 min and washed
once with 10 ml phosphate buffered saline (PBS). A total of 5 ×
107 bacteria in 100 µl of PBS containing 0.5% fetal calf serum
(FCS) and incubated with 50 µg/ml polyclonal rabbit IgG for
30 min at 37◦C. After washing the bacteria two times with PBS,
the bacterial pellet was suspended in 100 µl of PBS containing
a 1:250 dilution of an anti-rabbit ALEXA R© Fluor 488 antibody
or an anti-rabbit ALEXA R© Fluor 568 respectively and incubated
for 45 min at 37◦C. Bacteria were again washed two times
with 1 ml PBS, fixed by adding 3% paraformaldehyde in PBS
followed by flow cytometry analysis using a FACSCalibur (Becton
Dickinson). Streptococci were detected using log-forward and
log-side scatter dot plots, and a gating region was set to exclude
larger aggregates of bacteria. A total of 104 bacteria were analyzed
for fluorescence using log-scale amplification. Histograms of
representative results are shown.
Cloning and Expression of Truncated SCM
Fragments
Using plasmid pQE30-SCM (Fulde et al., 2011) as the
parental construct, a technique for generation of truncated
fragments was developed using inverse PCR-amplification.
Depending on the region of interest (C-terminal or N-terminal)
oligonucleotides were designed annealing either in the His-
tag region or downstream of the stop codon. An appropriate
internal oligonucleotide was designed for specific N-terminal
or C-terminal truncations, respectively. SCM KO173225, a
fragment with an internal deletion was generated by a
combination of internal oligonucleotides. A diagram illustrating
the cloning strategy is depicted in Supplementary Figure 1.
Oligonucleotides used in this study harbor a terminal EcoRV
restriction site and are listed inTable 1. The N-terminal 37 amino
acids were removed from recombinant SCM fragments, in order
to enable purification of the proteins out of the E. coli cytoplasm
as described below.
The inverse PCR was performed using the Phusion R©
High-Fidelity DNA Polymerase (Finnzymes) following the
manufacturer’s recommendations with the following parameters:
Initial denaturation: 98◦C, 30 s, denaturation: 98◦C, 10 s,
annealing: 60◦C, 30 s, elongation: 72◦C, 180 s, final elongation:
72◦C, 600 s. PCR amplificates were digested with EcoRV and
re-ligated using T4 DNA-Ligase (Promega) and subsequently
transformed into electrocompetent E. coli M15[pREP4]. Protein
expression was performed using the lactose-inducible expression
system of the vector pQE30 in the E. coli host strain M15[pREP4]
as described by the manufacturer (Qiagen ExpressionistTM
TABLE 1 | Oligonucleotides used in this study.
Fragment Oligonucleotide: 5′ → 3′*
N-173 gggqatatc TCTTGGCT AGCAGATAGTTGTGC
cccqatatcTGAGTCGACCTGCAGCCAAGC
N-207 gggqatatc GCAGAAATTGAGCGCTTGACA
cccqatatc TGAGTCGACCTGCAGCCAAG
N-225 qggqatatc CACTTCTGCTTGAAGTTTCTCG
cccqatatcTGAGTCGACCTGCAGCCAAG
C-67 cccqatatc TCGAAAAGAAGTGAAA T A TTT AG
gggqatatc TCCGTGATGGTGATGGTGATGCGATCC
C-90 cccqatatcTCATACTGATATGATTGAAAAAGAG
qggqatatcTCCGTGATGGTGATGGTGATGCGATCC
N-275 qggqatatcAGCTACTTT AGCTTGCTCTGCGGC
cccgatatcTGAGTCGACCTGCAGCCAAG
C-112 cccqatatc T AA T AAAGGTCTT ACT AAGG
gggqatatc TCCGTGATGGTGATGGTGATGCGATCC
C-142 cccqatatcAGCT AACCTTGACGCTTTGAACC
qggqatatcTCCGTGATGGTGATGGTGATGCGATCC
C-173 cccqatatc GAGCGT AACGCTGAGTT AGAGCG
qgggatatcTCCGTGATGGTGATGGTGATGCGATCC
C-202 cccqatatcAGAAATTGAGCGCTTGACAGCTG
qggqatatcTCCGTGATGGTGATGGTGATGCGATCC
C-226 cccgatatcTCAACACTTCGTGATCAAGTAGCAAGCC
gggqatatcTCCGTGATGGTGATGGTGATGCGATCC
K0173225 gggqatatc TCTTGGCT AGCAGATAGTTGTG
cccqatatcTCAACACTTCGTGATCAAGTAGCAAGCC
pQE30-Seq 5′ CCCGAAAAGTGCCACCTG
pQE30-Seq 3′ GTTCTGAGGTCATTACTGG
*EcoRV restriction site is underlined.
System). In brief, 400 ml of a bacterial culture was inoculated
with the recombinant E. coli clone and cultured at 37◦C
with aeration (shaking flasks at 280 rpm) until an optical
density at 600 nm of 0.6 (OD600). Protein expression was
induced by incubation with 1 mM of the lactose analogon
isopropyl-ß-D-thiogalactoside (IPTG) for 4 h at 28◦C and 140
rpm shaking. After sedimentation of the bacteria at 3,000 ×
g at 4◦C, the sediment was resuspended in 10 ml PBS and
mechanically lysed using a French Press (SLM Instruments).
After additional centrifugation at 10,000 × g for 30 min at 4◦C,
the supernatant was applied onto a prepacked and equilibrated
Protino NED 2000 Ni-NTA column (Macherey-Nagel) for
purification of His-tagged proteins by affinity chromatography.
The proteins were eluted from the Ni-NTA-columns by addition
of 250mM imidazole according to the recommendations of the
manufacturer. After dialysis of the eluted protein against PBS, the
protein concentrations were determined using Bradford assays
(Serva). Prior to binding studies, the quality of the truncated
proteins (presence of a single protein band, no degradation
products) was verified by SDS-PAGE.
Radioactive and Non-radioactive Dot Blot
Analysis
Radioactive Dot Blot analysis was carried out essentially as
described in Fulde et al. (2011). Briefly, IgGs derived from
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different host species as well as different subclasses of human IgG
were spotted onto a nitrocellulose membrane in a concentration
series. The membrane was blocked with 5% skimmed milk at
4◦C overnight. The following day, the membrane was washed
five times by moderate shaking for 10min at RT with 10ml
PBS supplemented with 0.05% Tween-20 (PBST). Hybridization
with 125I-SCM was performed for 4 h at room temperature (RT).
Hybridization (binding) was detected after exposure of X-ray
films (Kodak).
Non-radioactive Dot Blot analyses were performed for
determination of the minimal IgG interaction sites of the SCM
protein. Truncated fragments of SCM were immobilized by
spotting onto nitrocellulose membranes. Blocking and washing
procedures were performed as described previously (Fulde et al.,
2011). HRP-conjugated rabbit anti-goat antiserum was applied
as a ligand for interaction studies. Binding was detected by
chemiluminescence determination after incubation of the blots
with Pierce R© ECL Western Blotting substrate according to
the recommendations of the manufacturer. Signal development
was performed by exposure of Amersham ECL-Hyperfilm (GE
Healthcare) followed by an automated development with a
Typon C2 developer (NDTMED-Röntgentechnik).
Elisa
In addition to Dot Blot analyses, characterization of the IgG-
binding site of SCM was performed with ELISA. Different
concentrations of full-length or truncated SCM fragments (100,
50, 25, 12.5 µg/ml) were immobilized in a 96-well plate with 0.1
M NaHCO3 at pH 9.6. After blocking for 2 h at RT with 1%
BSA in PBST and three wash steps with PBST using a volume
of 100 µl, a 1:5000 dilution of polyclonal HRP-conjugated rabbit
anti-goat antiserum was added for 2 h. IgG- incubation without
proteins was used as negative control. Signal determination
was performed with 50 µl of tetramethyl bencidine substrate
solution (TMB, Thermo Fisher Scientific) as recommended by
the manufacturer. The enzyme reaction was stopped after 15 min
at RT by adding 50 µl of 2 N H2SO4 and the color reaction
was measured using an ELISA reader (Tecan Sunrise) at 450 nm
(reference wave length 570 nm). Experiments were repeated three
times using triplicate samples.
Competitive IgG binding studies have been carried out with
SCM and FOG, the M protein of S. dysgalactiae sub. equisimilis,
which harbors fibrinogen and IgG binding capability (Johansson
et al., 2004; Nitsche-Schmitz et al., 2007). In these assays, 10µg of
SCM, FOG, and the truncated SCM-fragment KO173225, which
lacks the internal IgG-binding region, were pre-incubated with
human HRP-conjugated IgG (1:200 dilution) for 15 min. Wells
of a 96-well plate were coated with 5 µg of full lengths SCM
protein in 0.1 M NaHCO3, pH 9.6. After blocking for 2 h at RT
with 1% BSA in PBST followed by three wash steps with PBST,
pre-incubatedmixtures of bacterial proteins with IgGwere added
to the SCM-coated wells and incubated for 2 h. IgG without
proteins was used as negative control in various concentration.
Signal determination was performed after incubation for 30 min
with 50 µl of activated 2,2′-Azino-di-(3-ethylbenzthiazolin)-6-
sulphonic acid (ABTS). The ABTS solution was prepared by
adding 100 µl of 3% H2O2 to 11 ml of substrate solution directly
before development reaction. The enzyme reaction was stopped
by adding 50 µl of 2N H2SO4. Signals were determined with an
ELISA reader (Tecan Sunrise) at 405 and 655 nm as reference.
Experiments were repeated three times using triplicate samples.
Detection of C1q Immobilization on the
Streptococcal Surface
Detection of C1q binding was performed according to the
protocol of Nitsche-Schmitz and colleagues with slight
modifications (Nitsche-Schmitz et al., 2007). Briefly, overnight
cultures of S. canis strain G361 (SCM+) and G2 (SCM−) as
well as SDSE strain G45 (FOG+) and G89 (FOG−) grown
in Todd Hewitt liquid medium (Difco) at 37◦C and 5% CO2
were sedimented by centrifugation at 1,400 × g for 10 min and
washed with PBS supplemented with 0.05% Tween-20 (PBST)
and resuspended in 3 ml of PBS in a concentration of 0.25 g of
bacteria/ml (wet weight/volume). Hundred microliters of this
suspension was incubated with 10 µg of human IgG (Sigma)
for 30 min at RT. Another 100 µl of the bacterial suspension
was incubated with 2 µg purified C1q (Calbiochem) for 1 h at
37◦C, and a third fraction was pre-incubated for 30 min at RT
with 10 µg IgG. After two wash steps with 1 ml PBS, 2 µg of
C1q was added to the pre-incubated suspension and incubated
at 37◦C for 1 h. Then, bacteria were washed three times with
PBS, and surface-bound proteins were eluted by incubation with
30 µl of 100 mM glycine, pH 2.0 for 15 min at RT followed by
centrifugation for 10 min at 1,400× g. Samples were neutralized
by addition of 1.5 M Tris-HCl, pH 8.8. Proteins were separated
by SDS-PAGE and blotted onto a nitrocellulose membrane.
Subsequent Western Blot analysis was performed essentially as
described (Nitsche-Schmitz et al., 2007).
Field Emission Scanning Electron
Microscopy (FESEM) for Visualization of
Bound IgG
S. canis strain 361, G15, G17 and strains G2 and 2424/96
were incubated with a 1:50 dilution in PBS of protein A-
purified IgG protein (stock solution 1,7 mg/ml) of pre-immune
serum of rabbit for 1 h at 37◦C. Bound IgG was visualized
by incubation with protein A-gold/protein G-gold nanoparticles
(ratio 1:1, 15 nm in size) for 30 min at 37◦C. After washing
with PBS and TE buffer (10 mM TRIS, 2 mM EDTA, pH
6,9), samples were placed onto butvar coated copper grids
and air dried. Grids were attached to adhesive carbon tape
on aluminum stubs and samples were examined in a Zeiss
Merlin (Oberkochen, Germany) applying the Everhart-Thornley
HESE2-secondar electron detector at an acceleration voltage of
10 kV. Images were taken with the Zeiss SmartSEM software
version 5.05. Contrast and brightness were adjusted with Adobe
Photoshop CS5.
SCM Phylogeny
Genomic DNA of 46 S. canis strains (Verkuehlen et al., 2016)
was used for PCR amplification of the IgG-binding region of
SCM using DreamTaqTM DNA Polymerase (ThermoScientific)
with DreamTaq green PCR Master Mix (ThermoScientific)
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according the manufacturers protocols with the following oligo-
nucleotides: SCM_bind_FP (5′–3′ ATC TGC TAG CCA AGA
GCG TA) and SCM_bind_RP (5′–3′ CAC TTC TGC TTG AAG
TTT CT) and the following temperature parameters: Initial
denaturation: 94◦C, 180 s, denaturation: 94◦C, 180 s, 30 cycles
of annealing: 58◦C, 30 s, elongation: 72◦C, 30 s, final elongation:
72◦C, 600 s. The obtained PCR-products were Sanger-sequenced
by LGC Genomics Company, Germany, which generated high-
quality sequences of approximately 169 bp. The sequences of the
IgG-binding region of SCM were aligned using the Geneious
Alignment with default parameters provided by the Geneious
7.0.2 software. The identified sequence variants were used as
template for a megablast search against the NCBI nucleotide
database in order to identify published reference sequences for
each sequence variant. Examples of each variant of the IgG-
binding region of SCM of the 46 S. canis strains, their identified
reference sequences as well as the IgG-binding region of SCM
of G1, G8, G13, G15, and G361 were aligned with the Geneious
Alignment and were used to generate a UPGMA tree using
Geneious Tree Builder with a Jukes-Cantor distance model.
M-like proteins of other streptococcal species were identified
using blastp with the protein sequence of the IgG-binding
region of SCM as query target against the NCBI protein
database. The identified protein sequences were aligned with
Geneious Alignment with a Blosum62 cost matrix and the
resulting alignment further used to generate a UPGMA tree using
Geneious Tree Builder with a Jukes-Cantor distance model.
Surface Plasmon Resonance (SPR)
Protein-protein interactions between SCM-WT or KO173225
and human IgG-Fc were analyzed by SPR using a BIAcoreT100
optical biosensor (GE Healthcare). Recombinant SCM and
KO173225 were immobilized as ligands on a carboxymethyl
dextran (CM5) sensor chip using standard amine-coupling
procedures as described earlier (Kohler et al., 2015). Briefly, SCM
and KO173225 proteins were adjusted to 10 µg/ml in 10 mM
acetate buffer (pH 4.0) and injected for surface immobilization
at a flow rate of 10 µl/min, followed by deactivation of residual
activated groups with 1 M ethanolamine. The resonance values
of the bound proteins (RU) reached ∼2,200 RU. The control
flow cell was prepared identically but without protein injection.
Binding analysis was performed with PBS containing 0.05%
Tween R©-20 (PBST) at 25◦C using a flow rate of 10 µl/min.
Regeneration of the affinity surface was carried out with 10 mM
glycin pH 3.0. The given resonance units (RU) in the sensograms
represent the RU values after subtraction of the values measured
in the blank chamber. Each interaction was measured at least
three times. Data were analyzed using BIAcoreT100 Evaluation
Software (version 2.0.1.1). Experimental data were fitted globally
using the simple one-step bimolecular association reaction (1:1
Langmuir kinetic: A+B↔AB).
Statistical Analyses
Unless stated otherwise, all experiments were repeated three
times using triplicate samples and results are presented as
mean values including standard deviations. Significance was
calculated using an one-way ANOVA followed by Dunnett’s post-
test. P-values < 0.05 are considered as significant. Significant
differences in data sets are indicated with an asterisk.
RESULTS
The Streptococcus canis M Protein SCM Is
a Bacterial Receptor for Immunoglobulin G
We recently identified SCM as an M protein of S. canis,
characterized by its affinity for the serum protein plasminogen
and its anti-phagocytic properties (Fulde et al., 2011, 2013a,b).
In the present study, we were interested in determining whether
the SCM protein might possess additional binding activities to
other serum proteins with immune-modulatory functions, in
particular immunoglobulin G. We, therefore, incubated different
SCM-positive and-negative S. canis strains with iodinated rabbit
IgG. IgG binding was detected for the majority of isolates with
percentages ranging from 13.93 ± 5.89% (strain 2,424) to 54.64
± 6.76% (strain 5468-1-10; Figure 1A). Strains Sc1 4074-03,
G2, G14, G15, G17, 2424/96, 1022/96, and 5520-2-10 showed
binding efficiencies lower than 10% and were classified as non-
IgG binders. Interestingly, with the exception of strain G15 (8.09
± 0.82% IgG binding), all non-IgG binding isolates harbor an
scm-negative genotype in the recently described all-scm PCR
(Fulde et al., 2011; Verkuehlen et al., 2016). These data strongly
suggested a role for SCM as an IgG receptor in S. canis. To
verify this hypothesis, the SCM-positive S. canis strains G15 and
G361 and the SCM-negative strains G2, G17, and 2424/96 were
incubated with Alexa 488-conjugated rabbit-anti goat antibody
(diluted 1:500 in PBS) and subjected to FACS analysis. As
expected, fluorescence intensity of strain G361 was substantially
increased in contrast to the SCM-negative strains G2 and
2424/96, respectively (filled curves, Figure 1B). Interestingly, an
intermediate phenotype was detected for the SCM-positive strain
G15 and the SCM-negative strain G17. The role of SCM as an
IgG receptor was further confirmed by flow cytometric analysis
of S. gordonii bacteria (SGO-SCM) heterologously expressing
SCM on their surface. As shown in Figure 1C, a substantial shift
in fluorescence intensity was observed for strain SGO-SCM but
not for its SCM-negative parental strain SGO-WT. These results
clearly demonstrated a role for S. canis SCM in IgG binding.
To further confirm the results from the binding studies with
iodinated IgG and FACS analysis, we visualized IgG binding by
field scanning electron microscopy. As depicted in Figure 1D, a
high amount of 15 nm dots (resembling gold-labeled IgGs) was
observed on the surface of SCM-positive strain G361, whereas the
SCM-negative strains G2 and 2424/96 were free of any electron-
dense particles (Figure 1D). Again, strains G15 and G17 exhibit
an intermediate phenotype with a reduced amount of surface-
bound IgG molecules.
Phenotypic Characterization of the
SCM—IgG Interaction
Since S. canis has been characterized as a zoonotic agent able
to cause infections in a variety of different hosts, we were
interested in the interaction of SCM with IgG derived from
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 March 2017 | Volume 7 | Article 80
Bergmann et al. Interaction of S. canis SCM with Immunoglobulin G
FIGURE 1 | IgG binding to S. canis. (A) Binding of iodinated IgG to 21 different scm-positive (black bars) and scm-negative (gray bars) S. canis isolates was
analyzed by gamma-counting. Data represent triplicates of three independent experiments and are presented as mean values ± standard deviation. IgG-binding to
scm-negative S. canis G2 and G2424/96, and G17, and to SCM-expressing S. canis G361 and G15 (B) as well as to S. gordonii bacteria (SGO) and heterologously
SCM-expressing S. gordonii bacteria (C) was analyzed by flow cytometry using polyclonal IgG raised in rabbit and fluorescence—conjugated secondary antibody. IgG
binding was detected for SCM-expressing S. canis strains and also for SCM-expressing S. gordonii. Histograms of representative results are shown. (D) Field
Transmission Electron microscopic visualization of the bacterial strains G361, G2424/96, G2, G15, and G17. Bound IgG was detected with protein A-gold
nanoparticles. FESEM analysis of S. canis G2 and G2424/96 revealed only marginal background binding, whereas strong IgG binding is shown for G361 and
moderate binding was visualized on the surface of G15 and G17 (white spheres). Bars represent 200 nm.
different species. Using Dot Blot analysis with iodinated SCM as
the ligand, a specific signal was detected for IgGs derived from
cats, dogs, horses, human, and rabbits (Table 2). Surprisingly,
although S. canis is frequently isolated frommastitis in ruminants
(Chaffer et al., 2005; Hassan et al., 2005), neither an interaction
with bovine nor with goat IgG was observed. In order to
determine (putative) bacterial species-specific differences, we
then incubated SCM with the different subtypes (IgG1, IgG2,
IgG3, and IgG4) of human IgG. However, as already shown
for the M protein FOG of SDSE (Nitsche-Schmitz et al., 2007),
a direct binding of SCM to IgG1, IgG2, and IgG4 but not to
IgG3 was observed (Table 2). Finally, this interaction is non-
opsonic, since Dot Blot analysis with iodinated SCM revealed
a specific signal for the conserved IgG-Fc part, but not for
IgG-Fab (Table 2). In summary, our data demonstrate a species-
specific, non-opsonic and potentially immune-modulatory mode
of SCM-IgG interaction.
Concurrent and Non-inhibitory Binding of
IgG and Plasminogen to SCM
In prior studies, we had identified plasminogen (PLG) as a
ligand for SCM (Fulde et al., 2011, 2013a,b). The detection
of IgG as an additional binding partner for SCM inevitably
raised the question as to whether PLG and IgG compete
for the same binding site on SCM. To answer this question,
we incubated the SCM-positive S. canis strain G361 with
iodinated IgG. As already shown in Figure 1A, a binding
capacity of ∼20.4 ± 4.5% was detected (Figure 2A). Excess,
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non-iodinated IgG (1 µM) showed a significant inhibition of
IgG-binding to ∼6.7 ± 0.9%. In contrast, addition of 1 µM
of plasminogen did not alter IgG-binding capacity of strain
G361 (22.3 ± 3.1%, Figure 2B). Similarly, incubation in the
presence of excessive non-radiolabeled plasminogen to S. canis
strain G361 PLG decreased iodinated PLG-binding capacity from
37.1 ± 1.5% to ∼23.3 ± 0.2. As expected, supplementation
of non-labeled IgG did not alter the PLG-binding capacity
of G361 (Figure 2A). These results clearly demonstrated a
concurrent binding of IgG and PLG to SCM, which occurs in a
non-competitive manner.
The IgG-Binding Site of SCM Is Located in
the Central Part of the Mature Protein
In order to identify binding site(s) for IgG, numerous C-
terminal, N-terminal, and truncated deletion fragments of SCM
were generated and tested for their IgG-binding activity using
quantitative Dot Blot assays and ELISA. The N-terminal SCM
fragments N-225 and N-275 revealed a strong IgG-binding signal
(Figure 3B, Supplementary Figures 2, 3). Reducing the length of
the truncated fragment to 136 amino acids (N-173), completely
abolished the IgG-binding. Generation of C-terminal fragments
by deletion of N-terminal amino acids enabled the detection
of positive binding for SCM fragments C-67, C-90, C-112,
C-142, and C-173, whereas, in accordance to the N-terminal
fragments, C-226 was negative for IgG binding (Figure 3B,
Supplementary Figures 2, 3). A deletion construct of mature
SCM which lacks a stretch of amino acids 173–225 (KO173225)
was also negative for IgG binding, defining this stretch of 52
amino acids located in the central part of the mature SCM as
important for IgG binding (Figure 3A).
The surface plasmon resonance (SPR) technique is a robust
and valid method to determine quality of protein-protein
interactions. To further define the interactions between SCM and
IgG, we immobilized SCM-WT on a CM5 sensor chip as a ligand
and applied human IgG-Fc in a series of concentrations (0.3–
10 µg/ml) as the analyte. The sensogram depicted in Figure 3C
shows a specific and dose-dependent binding of IgG-Fc to SCM.
A global fitting of response data according to the 1:1 Langmuir
model revealed an accurate data fit with low Chi2 -values and
indicated a simple 1:1 binding site interaction between IgG Fc
and SCM. The calculated dissociation constant for the binding
of IgG-Fc to SCM was 1.23−7 Mol, which indicates a strong and
physiologically relevant interaction (Supplementary Figure 5).
As a control, we included the deletion fragment KO173225,
which was negative for IgG binding in Dot Blot analysis, ELISA,
and SPR (Figures 3B,D, Supplementary Figures 3, 5).
The IgG-Binding Site of SCM Is Highly
Conserved among Different S. canis
Isolates and Other Animal-Specific and
Zoonotic Streptococci
The close association of the S. canis genotype (scm-positive)
with the ability of the respective isolate to interact with IgG
(Figure 1A), strongly suggested that the specific interaction site
defined above is highly conserved. To confirm this hypothesis,
TABLE 2 | Specificity of IgG-SCM interaction.
Species Binding
Dog +
Cat +
Cattle –
Horse +
Human +
Mouse +
Goat –
Rabbit +
hlgG-subclasses Binding
lgG1 +
lgG2 +
lgG3 –
lgG4 +
hlgG-fragments Binding
Fc +
Fab –
Iodinated SCM was applied as ligand in Dot Blot overlay analyses with immobilized IgG
derived from different species, with IgG subclasses 1–4 and IgG Fab- and Fc- fragments.
A positive signal was indicated with “+,” no binding was indicated with “–.”
we generated oligonucleotides which specifically amplified the
respective IgG-binding site and tested scm positive isolates of
a recently published S. canis strain collection derived from
different hosts (Verkuehlen et al., 2016). In addition, we included
the control strains G1, G8, G13, G15, and G361, which were
characterized as scm-positive, and, with exception of strain G15,
exhibited strong IgG-binding activity (Figure 1A). As expected,
the homology of the different IgG-binding regions comprising aa
173–225 of the mature protein is high (98.2 to 99.0% identity)
with only three SNP sites detected at positions 31 (A or G), 95
(C or T), and 149 (A or G) of the 169 bp nucleotide sequence
(Figure 4). The SNP in position 149, represented with nucleotide
A, was only detected in one S. canis strain (C120) and the
reference strain KU754284. This is the only non-synonymous
SNP among the detected SNPs, resulting in a lysine (K) instead of
glutamic acid (E) as represented by all other sequences. Finally,
a mammalian host-species dependent correlation between
the nucleotide sequences of bacterial SCM proteins was
not observed.
Analogous, but Not Homologous
IgG-Binding of SCM and FOG Has Different
Impact on the Opsonisation by C1q
Although the respective IgG-binding regions of SCM and FOG
differ significantly (Supplementary Figures 4, 6), both proteins
show high similarities in their binding behavior to IgG. For
example, both proteins mediate interactions with IgG via a
binding site which is located in the central part of the mature
M protein, both proteins lack a specific affinity for human
IgG3, and both proteins interact with IgG in a non-opsonic
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FIGURE 2 | Plasminogen and IgG binding of SCM. In radioactive inhibition studies binding of iodinated plasminogen (A) or iodinated IgG (B) to S. canis G361 was
determined after incubation with non-labeled IgG (1.0 µM) or plasminogen (1.0 µM). Data represent triplicates of three independent experiments and are presented as
mean values ± standard deviation. Significance was calculated using an one-way ANOVA followed by Dunnett’s post-test. **P-values < 0.01, ***P-values < 0.001.
manner. This observation prompted us to analyse whether
SCM and FOG share a common interaction site on the IgG
molecule. We therefore established a competitive ELISA in
which recombinant SCM was immobilized in the wells of a 96-
well plate. Subsequently, HRP-conjugated human IgG was pre-
incubated with 10 µg of recombinant SCM, FOG, or truncated
SCM fragment KO173225, respectively, before application to
the immobilized SCM protein. As shown in Figure 5A, pre-
incubation of IgG with SCM significantly decreased IgG-binding
to immobilized SCM to ∼20%. Similar results were observed
when IgG was pre-incubated with 10 µg FOG. However, as
expected, SCM-mediated IgG-binding was not affected when
pre-incubated with the truncated SCM fragment KO173225,
which lacks the specific IgG-binding site determined in this
study.
Nitsche-Schmitz and colleagues had previously demonstrated
that, in contrast to protein G, the interaction of the M protein
FOG with the Fc region of IgG allows an additional opsonisation
with the complement component C1q (Nitsche-Schmitz et al.,
2007). Taking the similarities of SCM and FOG in terms of
IgG-Fc- binding into account, we hypothesized that C1q is
also able to bind to the IgG-SCM complex. For validation, we
incubated the SCM-positive S. canis isolate G361, the SCM-
negative counterpart G2, as well as the FOG-positive SDSE strain
G45 and its FOG-negative deletion mutant G89 either with IgG
alone, with C1q alone, or with a combination of both IgG and
C1q. Bound proteins were eluted from the bacterial surface
and analyzed by Western Blot with antibodies directed against
C1q. As shown in Figure 5B, neither SDSE nor S. canis were
opsonized by C1q alone. However, as expected, pre-incubation
with IgG led to a FOG-dependent recruitment of C1q to the
surface of SDSE. In contrast, C1q was not detected on the
bacterial surface of S. canis, neither in the SCM-negative nor in
the SCM-positive strain. These results indicate that, in addition
to the strong phenotypic similarities in IgG-binding by SCM
and FOG, the impact on subsequent immune functions, such
as the recognition by the complement system, can be highly
variable.
DISCUSSION
Bacteria have evolved numerous strategies to circumvent
antibody-mediated killing. An ancestral, but widely distributed
mechanism among different bacterial species is the non-immune,
anti-opsonic binding of IgGs via their constant fragment
crystallizable (Fc) region (Forsgren and Sjöquist, 1969; Bjorck
and Kronvall, 1984; Zav’yalov et al., 1996; Lewis et al., 2008;
Leo and Goldman, 2009; Meehan et al., 2009). This interaction
consists of a simple competition inhibition between the bacterial-
and the IgG-Fc receptor expressed on the surface of professional
immune cells. In streptococci, the large family of M- and
M-like proteins constitutes bacterial IgG-Fc receptors. These
proteins share common structural and functional characteristics.
For example, M-and M-like proteins are surface-attached
fibrillar proteins and usually harbor a modular structure with
a homologous C-terminal and a variable N-terminal part.
In addition to IgG, M and M-like proteins constitute the
receptor for a variety of different host proteins from the serum
or the extracellular matrix, such as fibrinogen, plasminogen,
complement factors, and IgA (reviewed in Fischetti, 2016).
However, their most important feature is a specific anti-
phagocytic activity, which has been shown for M proteins, but
only suggested for M-like proteins (Metzgar and Zampolli, 2011;
Fulde et al., 2013a).
Streptococci expressing M proteins are subtyped by sequence
variations in the hypervariable, N-terminal region of the
corresponding emm genes, resulting in different M protein
serotypes (Metzgar and Zampolli, 2011). Although S. canis is
characterized as emm-negative, our group was able to identify
SCM, a protein with structural and functional characteristics of
M proteins. The anti-phagocytic activity of SCM is based on its
particular affinity for plasminogen, which confers a significant
protection against phagocytic attacks of polymorphnuclear
granulocytes (PMNs) (Fulde et al., 2013a). However, the
present study suggests additional roles for SCM with regard
to anti-phagocytic properties other than those mediated by
plasminogen-binding. As depicted in Figure 1, we clearly
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FIGURE 3 | Identification of the specific IgG-binding site in SCM of S. canis G361. (A) Summary of ELISA and quantitative Dot blot assays to study
IgG-binding activity by various C-terminal, N-terminal, and truncated SCM fragments. Positions of first and last amino acid of the fragments are indicated. IgG binding
activity is indicated with “+.” (B) The truncated N-terminal SCM fragments N-173 and N225, the C-terminal fragment C-173, and a fragment lacking the putative
IgG-binding region ranging from amino acid 173 to 225 were tested for IgG-binding activity by ELISA. (C,D) Interactions of soluble human IgG-Fc with immobilized
SCM-WT or KO173225 were analyzed by surface plasmon resonance spectroscopy. The representative sensograms show a dose-dependent binding of IgG-Fc to
SCM-WT whereas no binding was detectable for KO173225. The association and dissociation was observed, each of 300 s. Values of the control flow cells were
subtracted from each sensogram. The KD value is indicated.
demonstrated a strong and reliable correlation between the
scm-genotype and the IgG-binding phenotype of S. canis,
with only two exceptions. Isolate G15 is characterized as
scm-positive using the gene-specific PCR established in our
lab (Fulde et al., 2011), but failed to show a substantial
IgG-binding capability in radioactive binding assays and an
intermediate phenotype in FACS analysis. We consider two
explanations for this observation: (i) the particular isolate does
not express SCM at all, or (ii) the IgG-specific binding site of
the SCM protein is modified. This inconsistency was answered
by generating a variety of different truncated SCM fragments
to narrow down the IgG-binding site. Finally, we identified
a protein stretch of 52 amino acids located in the central
part of the mature protein which harbors IgG-binding activity
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FIGURE 4 | Nucleotide sequence alignment and phylogenetic analysis
of IgG-binding site sequences derived from SCM and other M proteins
of S. canis strains and their respective references obtained from the
nucleotide database of NCBI. The consensus nucleotide sequence is
displayed on top of the alignment followed by the respective amino acid
(Continued)
FIGURE 4 | Continued
translation. Within the alignment sequence, similarities are displayed with dots
and single nucleotide polymorphisms (SNPs) are shown with the regarding
nucleotide and amino acid in one letter code, if the SNP is a non-synonymous
one. Overall within the displayed IgG-binding region of SCM only three SNPs
were detected, with one non-synonymous SNP that is represented by only a
single strain and the associated reference sequence.
FIGURE 5 | Analogous rather than homologous interaction of SCM and
FOG with IgG-Fc and C1q. (A) Inhibition of IgG binding to SCM was
determined by in ELISA after incubation of 10 µg of M protein FOG, SCM, and
the truncated SCM protein fragment KO173225 (SCM-KO). Results represent
triplicates of three independent experiments and are presented as mean
values ± standard deviation. Significance was calculated using one-way
ANOVA followed by a Dunnett’s post-test. ***P-values< 0.001, ns, not
significant. (B) Different streptococcal strains harboring either a SCM- (G361)
or FOG- (G45) positive or a SCM- (G2) and FOG- (G89) negative genotype,
respectively, were co-incubated with IgG, C1q, or IgG and C1q in combination.
After eluting host proteins form the bacterial surface, immobilization of C1q
was determined in Western blot analysis using antibodies directed against
C1q. Recombinant C1q served as a positive control (co).
(Figure 3A). Subsequently, nucleotide sequence analyses and
sequence comparisons of scm alleles derived from a variety of
S. canis strains revealed a high homology with only three SNPs
occurring in the entire IgG-binding region. Using strain G361
as the reference strain, two of those SNPs are synonymous,
and do not lead to any changes in the deduced amino
acid sequence (Figure 4). The IgG-binding region of SCM
obtained from S. canis strain G15 does not differ from the scm
sequence of strain G361, strongly suggested that reduced SCM
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expression has led to the non-binding phenotype of strain G15.
In contrast, strain G17 is characterized as scm-negative but,
similar to G15, showed an intermediate IgG binding capacity
in radioactive binding experiments and FACS analysis. Again,
two explanations are reasonable. G17 might harbor a scm allele
which is not targeted by the all-scm PCR or, alternatively,
another protein expressed on the surface of G17 harbors IgG
binding capacity. Whole genome sequencing and subsequent
bioinformatic analysis would be a proper strategy for explaining
this phenomenon.
The central position of IgG-binding sites is a common
feature of streptococcal IgG-Fc receptors (Nitsche-Schmitz et al.,
2007; Meehan et al., 2009; Smeesters et al., 2010), which we
also observed for SCM (Figure 3A). As mentioned above, M-
and M-like proteins are characterized by a fibrillar structure
and a modular organization that roughly divides them into a
(hyper-) variable N-terminal part and a relatively conserved C-
terminal part. Variability in the N-terminus might be expected
due to continuous interaction with the host’s immune system
that inevitably shapes the M protein’s amino acid sequence and
constitutes, therefore, one of the numerous immune evasion
mechanisms of streptococci. The C-terminus, on the other hand,
is usually protected by the bacterial capsule, which prevents
direct contact between this part of the M protein and the host’s
immune system. As a consequence, the amino acid sequences of
streptococcalM proteins are highly conserved. The central region
of IgG-binding sites in M proteins appear to be contradictory
to its role as an immune evasion mechanism, since a direct
contact with the host’s immunoglobulins is abrogated. However,
capsule expression is a very dynamic process and can vary
depending on environmental and stress conditions, such as
nutrient availability or antibiotic treatments (Hammerschmidt
et al., 2005; Willenborg et al., 2011; Haas and Grenier, 2016;
Kietzman et al., 2016). Under nutrient-rich conditions, capsule
expression is highly upregulated which is consistent with
numerous studies characterizing the bacterial capsule as the
main virulence factor of streptococci in the blood (Wu et al.,
2014). In contrast, at tissue sites, where nutrient-availability is
likely restricted, capsule expression is downregulated, leading
to demasking of surface-anchored proteins which are otherwise
hidden. Mucosal surfaces constitute such tissue sites and S. canis
is a typical constituent of the respiratory and gastrointestinal
microbiota from dogs and cats (Devriese et al., 1992). The
microbiome is a complex entity shaped by numerous host-
intrinsic and-extrinsic factors. To be able to occupy a specific
niche in the host’s microbiota, S. canis has not only to compete
for nutrients with other resident bacteria, but also has to resist
the attacks of the immune system which are mainly executed
by secreted Igs. In a recent study, Nordenfelt and colleagues
nicely demonstrated the importance of the streptococcal IgG-
Fc receptors in vivo (Nordenfelt et al., 2012). The authors
found that at mucosal surfaces (in the throat), IgG is, indeed,
bound to the surface of GAS in a non-opsonic manner.
In contrast, the orientation of surface-bound antibodies is
reversed in the blood, which leads to a Fab-mediated bacterial
opsonization and subsequent phagocytic killing (Nordenfelt
et al., 2012).
The strict correlation between a scm-positive genotype and
the ability to interact with IgG strongly suggests that SCM is the
only IgG receptor in S. canis. This was an unexpected finding,
as its closest relatives, GAS and SDSE, usually contain more
than one IgG-Fc-binding protein (Bjorck and Kronvall, 1984;
Akesson et al., 1994; Frick et al., 1994, 1995; Jensen and Kilian,
2012). For example, SDSE harbors FOG and protein G, that
both belong to the large family of streptococcal M and M-like
proteins. FOG and protein G differ in their ligand specificity.
In addition to its strong affinity for fibrinogen, FOG interacts
with the human IgG subclasses IgG1, IgG2, and IgG4 (Nitsche-
Schmitz et al., 2007). However, protein G binds to albumin
and the entire collection of human IgG subtypes (Bjorck and
Kronvall, 1984; Wideback and Kronvall, 1987; Egesten et al.,
2011). The localization of the binding sites for FOG and protein
G on the IgG molecule appears to be either identical or at least in
close proximity, since both proteins specifically inhibit each other
in competitive binding experiments. Interestingly, the binding of
FOG to the Fc part of IgG allows an additional opsonization with
the complement component C1q, which is absent in protein G-
IgG interactions. Our studies on SCM-IgG interactions clearly
demonstrated that, in terms of ligand specificity, SCM resembles
the FOG phenotype and binds to the human IgG subclasses 1, 2,
and 4 (Table 2). On the other hand, SCM-mediated binding to
IgG specifically prevents C1q opsonisation (Figure 5B), which is
similar to the scenario described for protein G (Nitsche-Schmitz
et al., 2007). It seems that SCM of S. canis is a “functional”
intermediate between the two IgG-Fc receptors from other
GCGS and GAS. However, since sequence analysis of SCM did
not reveal any homologies with either the binding region of
protein G nor to the IgG-binding site of FOG or any other
known streptococcal M proteins (Supplementary Figure 6), we
conclude that streptococcal IgG-Fc receptors are of analogous
rather than of homologous nature. Interestingly, despite the
analogous nature, binding kinetics between streptococcal M
proteins and IgG do not vary tremendously. For example,
Lewis and colleagues found, that the M protein of Streptococcus
equi sub. equi (FgBP, for fibrinogen-binding protein) binds
to recombinant equine IgG4 and IgG7 with high affinity (Ka
values of 6.79−6 Mol and 6.96−6 Mol, respectively) (Lewis
et al., 2008). Nitsche-Schmitz and colleagues determined the
dissociation constant of the interaction between human IgG
and the S region, the IgG binding site of protein FOG, to
890 pM. However, when the FOG fragment comprised the S-
region together with additional flanking regions, the affinities
for IgG increased significantly (Nitsche-Schmitz et al., 2007).
We observed similar results, when different truncated fragments
of SCM were used to study SCM-IgG interactions (Figure 3B,
Supplementary Figure 2). A definitive reason is unknown but
it can be assumed that regions adjacent to the IgG binding site
might have a certain impact on the protein stability or tertiary
structure, respectively. Nevertheless, our data adds another piece
of evidence supporting the hypothesis of Frick and colleagues,
who postulated a convergent evolution among (streptococcal)
IgG binding proteins (Frick et al., 1992).
It is interesting to note that the genome of our reference strain
S. canis G361 (unpublished data), as well as the genome of a
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publically available S. canis strain (NZ_AIDX00000000), both
contain an open reading frame with the highest homology to
the N-terminus of protein G of SDSE. The resulting protein
is almost identical to protein DG12, which was characterized
by Sjöbring in the early 1990s (Sjobring, 1992). Protein DG12
was extracted from a group G streptococcus that was isolated
from a cow (strain DG12). Since S. canis is a classical causative
agent of bovine mastitis, it might be assumed that strain DG12,
which Sjöbring has classified as “group G streptococcus of
bovine origin” is actually S. canis. However, similar to protein
G, protein DG12 specifically interacts with human albumin,
but has entirely lost its ability to bind to IgG. Subsequent
in silico analyses of protein DG12 (or the S. canis’ protein
G homolog, respectively) revealed the presence of the GA
modules facilitating albumin-binding in protein G, but also
a complete lack of the C-terminal C repeats which mediate
IgG-Fc binding. Maintaining albumin-binding activity might be
advantageous for S. canis, since it promotes acquisition and
uptake of nutrients, such as fatty acids (Malmström et al., 2012),
but also facilitates antibacterial activity by interacting with the
chemokine MIG/CXCL9 (Egesten et al., 2011). However, the
question as to why S. canis has lost one of its Fc receptors crucial
for colonization of mucosal surfaces, is beyond the scope of this
study.
In summary, we present evidence for an additional feature of
the S. canisM protein SCM. Its role as an IgG-Fc receptor places
it within the large family of streptococcal M- and M-like proteins
which function as a bacterial receptors of multiple host proteins.
Its characterization as an M protein was previously established
due to its plasminogen binding activity. Whether the non-
opsonic binding to IgG or the immobilization of plasminogen,
or a synergistic action of both (Figure 2) constitutes the primary
anti-phagocytic mechanism, should be the subject of future
studies.
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Supplementary Figure 1 | Cloning strategy for truncated SCM fragments
by an inverse PCR approach. The mature SCM protein is depicted as a His-tag
fusion construct in plasmid pQE30. Arrows indicate oligonucleotides with
arrowheads pointing to the direction of transcription. Oligonucleotides comprise
an EcoRV restriction site at their C-terminus. For SCM fragments with truncations
in the N-terminus, a common forward primer was designed which is localized
downstream of the stop codon. Accordingly, truncated C-terminal fragments were
generated with a reverse primer located in the His-tag region. For construction of
the deletion fragment KO173225, internal primers were used.
Supplementary Figure 2 | Localization of the IgG-binding site on SCM. A
collection of different truncated fragments of SCM were immobilized in 96-well
plate in concentration-dependent manner. Binding was studied using a polyclonal
HRP-conjugated rabbit anti-goat antiserum.
Supplementary Figure 3 | Dot Blot analysis to narrow down the
IgG-binding site of SCM. Different truncated fragments of SCM were spotted in
a concentration series onto a PVDF membrane. Binding was evaluated using
HRP-conjugated rabbit anti-goat antibodies.
Supplementary Figure 4 | Phylogenetic distances of the sequence
alignment of the IgG-binding region of SCM and other M proteins and the
S region of FOG (AY600861). The alignment of the IgG-binding region of SCM
and other M proteins includes the same sequences as used for the alignment in
Figure 4. Additionally, the IgG-binding region (S region) of FOG is included into
the alignment to underline the vast difference (sequence identities of 48.3–49.9%)
between the IgG-binding sequence region of SCM and FOG, despite the known
IgG-binding capacity of both proteins.
Supplementary Figure 5 | Evaluation of BIAcore sensograms via Global Fit
according to 1:1 Langmuir binding model as offered by BIA evaluation
software. Table revealed chi2-values and kinetic parameter.
Supplementary Figure 6 | Phylogenetic distances of the sequence
alignment of M protein types harbored by streptococcal reference strains
additionally compared to the S region of the FOG protein of group G
Streptococcus sp. (AY600861 S region). Sequences of M proteins were used
of the following reference strains: PAB549986—Streptococcus dysgalactiae
subsp. equisimilis strain: RE214 (stg2078.0 type); FJ531841—Streptococcus sp.
“group G” isolate B11 (stCK401.3 type); DQ010932—Streptococcus sp. NS31
(stC5344.1 type); AB549993—Streptococcus dysgalactiae subsp. equisimilis
strain RE377 (stG10.0 type); JX028757—Streptococcus pyogenes (stCK401
type); JX028646—Streptococcus (emm55 type); KC978839—Streptococcus
pyogenes strain GLS469 (emm55 type). Differences vary between 52.4 and 100%
sequence identity.
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